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Abstract
 With insecticide resistance in malaria vectors spreading inBackground:
geographical range and intensity, there is a need for compounds with novel
modes of action to maintain the successes achieved to date by long-lasting
insecticidal nets and indoor residual sprays, used as part of an insecticide
resistance management strategy. Screening existing registered pesticides,
predominantly those developed for use in agriculture, may provide a more
rapid and less logistically challenging route to identifying active ingredients
of value to public health than screening and chemical synthesis
programmes for novel compounds.
 Insecticides and acaricides from all IRAC classes, includingMethods:
those with unclassified modes of action, were assessed for inclusion in a
laboratory bioassay testing cascade against adult female Anopheles
 mosquitoes. A longlist of representative candidate compoundsgambiae
was selected, excluding those with safety concerns, unsuitable
physiochemical properties, and likely hurdles to registration for public
health use.  An initial screen using topical application eliminated
compounds with insufficient intrinsic activity, and a tarsal contact assay
identified those with activity at an appropriate concentration. Compounds of
interest were ranked by relative potency using dose response assays and
discriminating dose calculations.
 Inclusion of an adjuvant enhanced the tarsal efficacy of severalResults:
compounds, facilitating the promotion of chemistries with great potential,
given suitable formulation, which would not progress based on activity of
compound alone. Comparison of data between stages in the testing
cascade suggest that a more streamlined approach, topical application to
test for intrinsic activity and determining the discriminating dose to compare
relative potency of compounds, may be sufficient to identify compounds
with potential value for use in long lasting insecticidal nets and indoor
residual spray products.
 Identified were 11 compounds of interest as vector controlConclusions:
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 Identified were 11 compounds of interest as vector controlConclusions:
agents (in descending order of potency): clothianidin, spinetoram,
metaflumizone, dinotefuran, indoxacarb, abamectin, sulfoxaflor,
oxazosulfyl, triflumezopyrim, fenpyroximate, and tolfenpyrad.
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Introduction
Long-lasting insecticidal nets (LNs) and Indoor Residual Sprays 
(IRS) are the most widely used and effective vector control 
interventions for the control of malaria and other mosquito-
borne diseases (Bhatt et al., 2015). Until recently, pyrethroids 
were the only class of insecticides used in LNs (World Health 
Organisation, 2015) with chlorfenapyr (N’Guessan et al., 2016) 
and pyriproxifen (Ngufor et al., 2014) being included more 
recently. Four additional classes of insecticides are currently 
used for IRS (organophosphates, carbamates, organochlorines 
and, recently, neonicotinoids; World Health Organisation, 2016). 
Increasing spread and intensity of insecticide resistance amongst 
African malaria vectors (Ranson & Lissenden, 2016) threatens to 
reverse the progress that has been made in recent years (World 
Health Organisation, 2019). To restore the efficacy of these 
vector control tools, insecticides that overcome existing 
resistance phenotypes and that are compatible for use in LNs 
and IRS must be identified (Hemingway et al., 2016).
High-throughput screening of existing compound libraries 
and chemical synthesis programmes provide an opportunity to 
identify novel insecticides, but are costly, risky and take 
a long time from initiation to delivery as a vector control tool 
to the market (Turner et al., 2016). The cost of bringing a new 
crop protection product to market was estimated to be $286m 
in 2014 (McDougall, 2016), and though the cost of developing 
a dedicated vector control insecticide would be lower, the total 
market for all public health insecticides may be only around 
$400m (BMGF and BCG, 2007).
Repurposing of existing insecticides originally developed for 
non-vector control uses provides an alternative strategy for 
the development of vector control products containing active 
ingredients with new modes of action, benefiting from pre-existing 
registrations and manufacturing knowhow and, consequently, 
shorter development time, reduced risk and lower costs (Hoppé 
et al., 2016). Repurposing of active ingredients with modes of 
action that circumvent the resistance mechanisms associated 
with traditional neurotoxic insecticides such as pyrethroids, 
carbamates and organophosphates have been demonstrated as 
a means of delivering new insecticidal products, including 
Interceptor G2, a LN based on chlorfenapyr, developed by BASF 
for agriculture and urban pest control.
The Innovative Vector Control Consortium (IVCC) is a product 
development partnership established in 2005 with the aim of 
overcoming the market failures which inhibit the development of 
new insecticides for public health use by supporting the devel-
opment of a range of new compounds and technologies for the 
control of mosquito populations in malaria endemic countries 
(Hemingway et al., 2006). In addition to IVCC’s efforts to develop 
completely novel compounds for vector control, this study was 
initiated to develop a laboratory bioassay cascade to screen 
existing agrochemical insecticides with no previous history 
of use in vector control that may have potential for LN and/or 
IRS uses and which offer new modes of action.
As the starting point for the testing cascade was insecticides 
that have already completed commercial development, a high 
throughput bioassay system, such as the larval screen developed 
by Matthews et al. (2018) was not necessary. Therefore, screen-
ing began with topical application to adult female mosquitoes. 
This served as a rapid first step to eliminate compounds with low 
intrinsic insecticidal activity against mosquitoes. However, as 
the potential uses being explored were for LN and IRS, all of the 
subsequent steps were based on insecticidal efficacy via tarsal 
contact. Tarsal contact assays were then run both with and without 
Mero, rapeseed oil, methyl ester with an added emulsifier, which 
is a wetting agent developed for use with herbicides, hereafter 
referred to as RME. The addition of an adjuvant prevents the 
crystallisation of an insecticide on a glass surface and seems to 
improve bioavailability and hence uptake by exposed insects 
(Ohashi et al., 2018). The inclusion of an additional step with 
an adjuvant was expected to increase the sensitivity of the 
bioassays. Knock down of mosquitoes immediately after topical 
and tarsal exposure was observed in addition to mortality; 
although pyrethroids are known for their rapid effects on mosquito 
vectors, some compounds with different modes of action may be 
slower acting.
Methods
Compiling the list of compounds to include in the screening 
cascade
To evaluate the testing cascade, it was first necessary to compile 
a list of potential pesticides for inclusion in the project. The initial 
list included representative insecticides and acaricides from 
all Insecticide Resistance Action Committee (IRAC) mode of 
action classes including those with unclassified mode of action 
(IRAC, 2018). The initial list of 620 pesticidal active ingredi-
ents was reviewed to produce a shortlist of candidate compounds 
for testing. The criteria for determining which insecticides to 
include or eliminate from the list included a) elimination of 
insecticides from classes with current or historical vector con-
trol use (e.g. organochlorines, organophosphates, carbamates 
and pyrethroids); b) Elimination of active ingredients that did 
not have a current registration with at least one stringent regula-
tory authority (e.g. US EPA, EU Biocides, Japan etc.); and finally 
c) exclusion of arsenic based insecticides and cyclodienes on 
the grounds of safety, fumigants on the grounds of physiochemi-
cal properties, and insect growth regulators (juvenile hormone 
analogues, ecdysone antagonists etc.) because the focus of the 
project was on identifying compounds causing direct mortality.
Where classes were represented by a number of active ingre-
dients, one or two representative candidates were selected 
for initial screening. This resulted in a refined list of 
40 compounds (Figure 1).
Samples of technical-grade active ingredients were obtained 
either from commercial suppliers or via custom synthesis.
Rearing mosquitoes for bioassays
All tests were carried out using 2-5-day-old non-blood-fed 
female mosquitoes of the insecticide-susceptible Kisumu strain of 
Anopheles gambiae s.s. reared in the Liverpool Insect Testing 
Establishment (LITE) insectaries at the Liverpool School of 
Tropical Medicine (LSTM) (Edi et al., 2012). Insectaries were 
maintained at 26°C ± 2°C and 80% relative humidity ± 10%. 
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Figure 1. Testing cascade to screen existing insecticides for use against mosquito disease vectors, including key findings. Intrinsic 
insecticidal activity is measured by topical application of compound directly onto adult female Anopheles gambiae mosquitoes, activity 
through tarsal contact is measured in a bioassay with and without RME as an adjuvant, and relative potency is judged by determining the 
discriminating dose in CDC bottle bioassays. Activity in Phase I was defined as ≥80% mortality 24 hours after topical application, and the 
breakpoint denotes the concentration at which activity was first observed; ‘>1’ means that activity was not observed even when the highest 
concentration, 1% active ingredient, was applied. Activity in Phase II was defined as ≥80% mortality 24 hours after tarsal exposure, and the 
breakpoint denotes the concentration ay which activity was first observed; ‘>125’ means that activity was not observed even at the highest 
concentration tested, 125 mg/m2. Compounds which were only active in tarsal contact bioassays (Phase II) in the presence and not the 
absence of RME are highlighted in red. Of 40 compounds from 20 IRAC MoA classes, and 7 compounds not listed or not classified by IRAC, 
11 compounds are shortlisted for further investigation. The hexagon symbol denotes compounds which showed insecticidal activity during 
screening but which were not progressed for other reasons.
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Larvae were fed ground fish food (Tetramin tropical flakes, 
Tetra, Blacksburg, VA, USA) and adults maintained on 10% 
sucrose solution fed ad libitum. For egg production, female adults 
were fed on human blood procured from the non-clinical blood 
product stock from the UK blood bank up until November 2016. 
After this point adult mosquitoes were fed on defibrinated horse 
blood supplied by TCS Biosciences. Mosquitoes were reared 
under a L12:D12 hour light:dark cycle with a 1 hour dawn 
and dusk.
Intrinsic activity measured by topical application
A total of three replicates of ten mosquitoes were treated by 
topical application with 0.01, 0.1 and 1% solutions of each 
compound solubilised in acetone, with solvent-only (negative 
control) and with 0.1% Permethrin in acetone (positive control). 
Mosquitoes were anesthetized for 30 seconds using carbon 
dioxide, distributed across a Petri dish lined with filter paper 
(Whatman, Grade 1) with the dorsal thorax exposed, and placed 
onto a 4°C chill table (BioQuip products, Rancho Dominguez, 
CA). A 0.25-µl droplet of insecticide solution was applied to the 
dorsal thorax using a 1 cm3 syringe and a hand-operated micro 
applicator (Burkhard Scientific, Uxbridge, UK). Mosquitoes 
were then transferred to holding cups, supplied with 10% sucrose 
solution, and held in a stability cabinet kept at 26°C ±2°C and 
70% RH ±10% under a L12:D12 hour light: dark cycle. 
Mosquitoes were scored for knock down or mortality 24 hours 
and 48 hours after topical application, according to the 
World Health Organisation (WHO) definition (World Health 
Organisation, 2018), a mosquito being classified as “dead” or 
“knocked down” if it is immobile or unable to stand or take 
off. After testing the first batch of compounds, an additional 
observation time was added to measure immediate effect on 
mosquitoes, with knock down being scored 60 minutes after 
topical application.
Further screen for efficacy: tarsal contact assay with and 
without the addition of RME
A total of three replicates of ten mosquitoes were exposed to 
0.05, 0.25, 1.25, 5, 25 and 125 mg/m2 of each insecticide applied 
in acetone to glass Petri dishes (radius 2.5cm, area 19.635cm2, 
SLS, Nottingham, UK). Petri dishes treated with 0.05 and 5 mg/m2 
permethrin were also included as positive controls and Petri 
dishes treated with acetone-only as a negative control. A 
500-µl aliquot of 0.000002, 0.00001, 0.00002, 0.0001, 0.0005, 
0.002, 0.01 and 0.05% solutions of each insecticide solubilised 
in acetone were applied to glass Petri dishes and dishes placed 
onto an orbital shaker for 4 hours to provide an even coating 
of insecticide across the dish during evaporation of the acetone.
Bioassays were conducted immediately after the 4-hour drying 
period, at 26°C ±2°C and ambient humidity. A 25-ml plastic deli 
pot (Cater4you, High Wycombe, UK) with a hole melted through 
the base was fixed onto each Petri dish with Parafilm. Mosquitoes 
were introduced through the hole and, after exposing them to the 
treated surface for 30 minutes, they were aspirated out and 
transferred to holding cups. Mosquitoes were scored for knock 
down immediately after being placed into the cups, 30 minutes 
after the start of exposure. Mosquitoes were then held as for the 
topical application assay and scored for mortality 24 and 48 hours 
after exposure.
The assay was repeated for each compound with the addition of 
RME (Mero, Bayer, Reading, UK: 81.4% w/w rapeseed fatty 
acid esters and emulsifier ethoxy (7) tridecanol) in combination 
with each insecticide. A 0.392 mg/ml RME in acetone solution 
(a concentration based on a typical field application rate) was 
used to prepare insecticide dilutions, which were applied to the 
glass Petri dishes to give a final application rate of 100 g/m2 RME 
and the bioassay conducted as described above.
Judging relative potency by determining discriminating 
doses
The discriminating dose (DD) of 11 compounds (dinotefuran, 
clothianidin, sulfoxaflor, triflumezopyrim, spinetoram, abamectin, 
fenpyroximate, Tolfenpyrad, indoxacarb, metaflumizone and 
oxazosulfyl) was established using a variation of the CDC bottle 
bioassay test (Brogdon & Chan, 2010). Wheaton bottles (250 ml, 
Fisher Scientific, Loughborough, UK) were coated with active 
ingredient dissolved in acetone as described, but with the addi-
tion of with 1.5 mg/bottle of RME. Bioassays were conducted a 
minimum of an hour and no more than 24 hours after coating, at 
26°C ±2°C and 70% ± 10% relative humidity. A total of 25 female 
mosquitoes were added to the test bottles alongside a negative 
control bottle containing acetone and RME only, and a positive 
control bottle containing 20 µg/bottle permethrin applied in 
acetone but without RME. After a 60-minute exposure, mos-
quitoes were transferred from the bottles into holding cups, and 
scored as knocked down or dead if they are immobile or unable to 
stand as described by Brogdon & Chan (2010). Mosquitoes 
were held as for topical and tarsal contact assays, and mortality 
scored 24 hours after exposure. Mosquitoes were exposed to dif-
ferent concentrations (reported in µg/bottle) of compounds until 
data was collected from concentrations which produced mortal-
ity values covering the whole range from 0–100%. These data 
were used to calculate the DD of each compound.
Data analysis
Percentage knock down and percentage mortality were calcu-
lated from the total number of mosquitoes in each replicate of the 
topical and tarsal assays counted at the end of the experiments. 
If mortality in the topical application or tarsal contact test 
negative control was between 5 and 20% mortality in test repli-
cates was corrected for negative control mortality using Abbott’s 
formula (Abbott, 1925), with negative values reported as 0% 
mortality. If control mortality was above 20% at 24 hours after 
exposure the test was repeated. Breakpoints were determined as 
being the lowest concentration at which 80% or more of mos-
quitoes were killed within 24 hours of exposure. Compounds 
which failed to reach 80% mortality at 24 hours after topical 
application or tarsal contact exposure with RME were rejected 
from further testing in the cascade.
To calculate a DD for each compound, 24-hour mortality data 
was included from at least n=50 mosquitoes exposed to each 
concentration used in the analysis. Data from concentrations 
below the highest tested concentration that gave 0% mortality 24 
hours after exposure, above the lowest tested concentration that 
gave 100% mortality, and those with an n value lower than 50 
were excluded from data analysis. The number of subjects n and 
the number of responders r were aggregated across the replicates 
for each concentration, and these data were analysed to determine 
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LC95 values for each compound using PoloPlus software (Version 
2.1, LeOra Software), via log-probit analysis (Robertson et al., 
1980). This calculated LC95 value was then multiplied by three to 
give a discriminating dose (LC95×3=DD), and compounds were 
ranked for relative potency: a low DD indicates a higher potency. 
This differs from the standard WHO discriminating dosages 
which are defined as being twice the experimentally derived 100% 
lethal concentration (LC100 value) of a reference susceptible 
strain (World Health Organisation, 1998).
Results
Forty compounds were included in the testing cascade, first 
tested for activity when applied topically, then for activity on 
tarsal exposure alone and in the presence of RME as an adjuvant, 
to identify a shortlist of 11 compounds which have potential for 
use to control Anopheles vectors of disease, which were then 
ranked for relative potency by calculating their DD. An overview 
of the data is presented in Figure 1. During the completion of 
the study additional information was gathered about the com-
pounds of interest, beyond entomological activity, and some com-
pounds were not progressed in the cascade despite demonstrating 
efficacy, as described below and summarised in Figure 2.
Intrinsic activity measured by topical application
Mortality observed 24 hours after topical application of 
40 compounds is presented in Table 1, together with knock down 
observed 60 minutes after topical application where these data were 
collected. Major differences were evident between the insecticidal 
efficacy of test chemicals in terms of the level of knock down and 
mortality they caused, demonstrating the sensitivity of the method. 
Activity was not determined relative to the positive control as only 
a single concentration of permethrin was applied (0.1%). The 
positive control consistently resulted in 100% mortality.
A total of 40 compounds were screened in this initial step in the 
testing cascade, of which 17 failed to reach the 80% mortality 
threshold 24 hours after application of the highest dose. Of these, 
13 were eliminated at this stage but five compounds (diafenthiuron, 
fenazaquin, tyclopyrazoflor, benzpyrimoxan and dicloromezotiaz) 
were taken forward to testing in the tarsal contact assays in order 
to validate topical application as a first step in the testing cascade. 
There were ten compounds that reached the threshold of activity 
at 0.01%, the lowest concentration tested; six reached the thresh-
old at the intermediate dose of 0.1%. On reviewing these results 
and other available information about the compounds, 15 of these 
23 compounds were taken forward to the next step of the testing 
cascade. 
There were eight compounds which showed activity in the 
topical application screen that were not taken forward for further 
testing for reasons other than insecticidal efficacy. Tebufenpyrad 
was rejected because four other active mitochondrial com-
plex I electron transport inhibitors were already being taken 
forward. Fenazaflor was rejected as it was no longer commercially 
available. Ethiprole and nitenpyram showed acceptable activity 
with topical application but were not taken forward in the test-
ing cascade due to their high water solubility as this made them 
unsuitable for use in LNs, the priority development area for IVCC 
at the current time, but may have potential for use in IRS. Flumeth-
rin and imiprothrin were included in this initial topical applica-
tion screen as potential alternative pyrethroids. They were active 
at the lowest concentration tested and may be useful in providing 
alternatives to existing pyrethroids used on LNs. However, they 
did not meet the key criteria of this study, being alternatives to 
pyrethroids with novel modes of action for vector control, and so 
were not taken forward at this time. Formetanate hydrochloride 
and amitraz were rejected despite being active in topical 
application due to perceived regulatory challenges.
Mortality was assessed at 24 and 48 hours after topical 
application of the test compounds. However, only seven 
compounds gave more than a 20% increase in mortality between 
these two time points, and in each case only with one of the three 
concentrations tested (Lees et al., 2019). For four compounds 
the breakpoint (concentration giving 80% mortality) decreased 
between 24-hour and 48-hour observations: dinotefuran from 
1 to 0.01%; sulfoxaflor from 1 to 0.1%; and pyrifluquinazon 
and tyclopyrazoflor which did not reach 80% mortality based on 
24-hour observation, but by 48 hours post-exposure the threshold 
was reached at the highest concentration, 1 %. 
For 31 compounds, knockdown was assessed 60 minutes after 
topical application in addition to assessment of mortality, and 
Figure 2. Fate of the 40 compounds taken through the testing 
cascade. In general, compounds which were active (≥80% mortality 
24 hours after exposure) in topical application were progressed to 
tarsal contact assays, and those active at this step were progressed 
to measure relative potency through determining their discriminating 
dose. However, of the 23 compounds which were active when 
applied topically, not all were progressed to tarsal contact testing 
due to a range of considerations including physicochemical 
properties and regulatory challenges foreseen in their development. 
Of the compounds which were active in tarsal contact assays, 
only a representative compound from each IRAC MoA class were 
progressed, with the exception of fenpyroximate and tolfenpyrad, 
both from class 21A.
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Table 1. Effect of topical application of forty compounds on adult female Anopheles gambiae. Knock down 
and mortality was observed 60 minutes and 24 hours after topical application, respectively, and were corrected 
for negative control mortality using Abbott’s formula (Abbott, 1925). UN denotes a compound listed by IRAC 
(2018) with unknown or uncertain mode of action. Compounds indicated as being unclassified have not been 
listed by IRAC (2018). ND indicates a data point which was not collected.
IRAC Class Compound Name Mean % Knock Down Mean % Mortality Breakpoint 
(% AI)0.01% 0.1% 1% 0.01% 0.1% 1%
1A Formetanate 
hydrochloride
ND ND ND 81.50 86.20 90.00 0.01
2B Ethiprole ND ND ND 100.00 100.00 100.00 0.01
3A
Flumethrin 6.67 86.67 96.88 96.70 100.00 96.70 0.01
Imiprothrin ND ND ND 96.70 96.70 100.00 0.01
4A
Dinotefuran 74.42 100.00 100.00 65.13 0.00 100.00 1
Clothianidin 80.65 81.25 93.10 100.00 96.49 96.49 0.1
Nitenpyram 96.88 100.00 100.00 96.56 100.00 100.00 0.1
Thiacloprid 63.33 81.25 86.67 19.00 0.00 42.33 >1
4C Sulfoxaflor 37.68 50.00 93.33 58.52 78.61 100.00 1
4D Flupyradifurone ND ND ND 48.20 33.30 73.60 >1
4E Triflumezopyrim 29.17 64.44 92.96 55.50 89.12 100.00 0.1
5 Spinetoram 90.00 76.67 90.00 92.56 100.00 100.00 0.01
6
Ivermectin 13.10 35.69 60.98 100.00 100.00 100.00 0.01
Tetranactin ND ND ND 0.00 0.00 3.54 >1
Avermectin ND ND ND 73.00 100.00 100.00 0.1
Abamectin 0.00 19.35 35.71 100.00 100.00 95.80 0.01
9B Pyrifluquinazon 86.67 45.16 80.77 46.37 18.11 77.85 >1
12A Diafenthiuron 3.23 85.19 72.73 19.31 11.68 20.50 >1
14
Cartap Hydrochloride 77.42 100.00 100.00 13.40 30.00 40.00 >1
Thiosultap-disodium 9.09 6.67 44.44 19.22 0.00 42.33 >1
19 Amitraz ND ND ND 97.50 86.70 79.30 0.1
21A
Tebufenpyrad 41.38 60.00 74.07 0.58 34.60 82.93 1
Fenpyroximate 96.77 100.00 100.00 85.22 96.22 82.36 0.01
Tolfenpyrad 47.58 90.91 100.00 100.00 100.00 100.00 0.01
Pyridaben ND ND ND 42.00 94.00 76.00 0.1
Fenazaquin 3.33 5.56 31.85 3.98 31.33 70.42 >1
Pyrimidifen 45.45 96.67 100.00 64.63 100.00 100.00 0.1
22A Indoxacarb 3.70 3.33 0.00 68.15 76.67 100.00 1
22B Metaflumizone 14.29 27.59 25.00 92.90 96.60 96.40 0.01
23 Spiromesifen ND ND ND 0.00 0.00 10.00 >1
25A Cyenopyrafen 0.00 0.00 0.00 10.00 3.33 6.66 >1
28 Flubendiamide 3.33 3.33 6.67 16.70 16.70 3.30 >1
29 Flonicamid 3.33 10.34 56.67 6.70 13.80 30.00 >1
UN Pyridalyl 0.00 0.33 0.00 0.00 0.00 0.78 >1
Unclassified
Closantel 6.67 10.00 10.00 0.00 7.11 32.08 >1
Fenazaflor 3.33 82.76 71.88 0.00 77.81 89.92 1
Tyclopyrazoflor 14.44 35.02 38.18 38.89 46.46 66.67 >1
Oxazosulfyl 25.45 25.45 50.34 70.91 74.85 96.67 1
Benzpyrimoxan 0.00 0.00 3.33 0.65 0.00 8.53 >1
Dicloromezotiaz 0.00 0.00 0.00 0.00 0.00 2.54 >1
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breakpoints were determined. Four compounds (spinetoram, 
fenpyroximate and pyrimidifen) had the same breakpoint for knock 
down and mortality, indicating relatively rapid action, whilst for 
nine compounds, a lower breakpoint was observed at 24-hour 
mortality, indicating slow action. Within this latter list of 
compounds, ivermectin, abamectin and metaflumizone stand out 
as being effective in terms of mortality but gave very low knock 
down rates. The breakpoint was lower when scored at 60 minutes 
in nine compounds, indicating some recovery from knock down 
during the subsequent holding period: thiacloprid, pyrifluquinazon, 
diafenthiuron and cartap hydrochloride were particularly active 
in terms of knock down but failed to achieve 80% mortality 
at 24 hours.
Further screen for Efficacy: Tarsal contact assay with and 
without the addition of RME
A total of 16 compounds from nine IRAC MoA classes, plus four 
which are unclassified by IRAC (20 compounds in total), were 
taken forward to be tested in tarsal contact bioassays with and 
without RME as an adjuvant. Knockdown 60 minutes after 
exposure and mortality 24 hours after exposure, in the presence 
and absence of RME, is presented in Table 2. Only five 
compounds, dinotefuran, avermectin, abamectin, tolfenpyrad and 
ivermectin achieved 80% mortality 24 hours post-exposure in 
the absence of RME, at any of the doses tested. 
An additional 11 compounds, from eight different IRAC MoA 
classes plus one unclassified compound, reached 80% mortality 
in the tarsal test in the presence of RME. All compounds which 
achieved 80% mortality in tarsal bioassays did so at a lower 
concentration in the presence of the adjuvant RME. 
Of the 16 compounds which were thus judged to be active in tar-
sal contact assays, 11 were taken forward to the next stage in the 
testing cascade, fenazaquin had previously been rejected due to 
low activity at topical application, and the other four were not 
progressed since they were represented by other compounds in 
the same IRAC class. Tolfenpyrad and fenpyroximate were taken 
forward as the most efficacious mitochondrial complex I electron 
transport inhibitors, and abamectin was taken forward to repre-
sent the avermectin class due to the availability of commercial 
formulations. 
The five compounds which did not show activity in the topi-
cal application screen but which were included for method 
validation purposes also did not reach the 80% mortality thresh-
old in tarsal contact assays either with or without the addition of 
RME, with the exception of fenazaquin which was active only 
at the highest concentration tested (125 µg/bottle) and only 
with the addition of RME.
Initially, mortality was assessed 24 and 48 hours after exposure. 
However, no compound gave more than a 10% increase in 
mortality between the 24-hour and 48-hour assessments in any 
tarsal assay with or without the addition of RME. Therefore, 
a 48-hour mortality assessment was not included for all 
compounds and mortality data is presented here at the 24-hour 
assessment only (Table 2). 
Compounds were defined as fast acting if more than 80% knock 
down was observed immediately post-exposure at the breakpoint 
concentration. Based on tarsal contact in the absence of RME, 
only dinotefuran was judged to be fast acting, but with the 
addition of RME, fenpyroximate, pyridaben, fenazaquin, 
pyrimidifen and tolfenpyrad were also judged to be fast acting 
(although knock down was not scored for oxazosulfyl or 
Indoxacarb). Of these, fenpyroximate and pyrimidifen had also 
been judged to be fast acting through topical application.
Judging relative potency by calculating DD
A total of 11 compounds were shortlisted after review of the 
results from tarsal contact assays. Discriminating doses, 
calculated from 24-hour mortality data from bottle bioassays in 
the presence of RME and ranked in order of potency, are shown in 
Figure 3. The LC95 values from log-probit analysis ranged from 
8.07 µg/bottle for clothianidin to 1101.44 µg/bottle for tolfen-
pyrad. Clothianidin had a significantly greater potency than any 
other compound on the short list, followed by spinetoram and 
metaflumizone which were significantly more potent than all other 
compounds except dinotefuran (95% CI, log-probit analysis). 
In order to compare these results with results from the previous 
step in the testing cascade, compounds were ranked by DD and 
by breakpoint in the tarsal contact assay with RME, and these 
ranks plotted against each other (Figure 4) to show the 
correlation. The chemical structures of these 11 compounds are 
shown in Figure 5.
Discussion
Evaluating the testing cascade
The testing cascade described here was designed to fulfil two 
purposes: firstly, to identify existing crop protection and animal 
health insecticides which have intrinsic activity against mos-
quito vectors of disease and potential for use in public health; and 
secondly to assess their efficacy via tarsal contact. The potential 
for improved activity in an appropriate formulation was explored 
through the inclusion of an adjuvant, RME. Finally, compounds 
were ranked by relative potency by determining their discrimi-
nating dose. Forty compounds were taken through this cascade 
to explore its usefulness to facilitate evidence-based decision 
making on which compounds should be investigated further. 
Following inclusion of factors other than insecticidal effi-
cacy, including safety, regulatory environment and availability, 
a shortlist of 11 compounds with potential for formulation 
into mosquito vector control products is proposed.
Topical application of active ingredients in a volatile solvent 
does not reflect the way that mosquitoes would be exposed to 
insecticides in an LN or IRS product and, in this sense, is a less 
realistic screen than the tarsal contact assay. However, it is 
recommended by WHO as the first step in screening adulticides 
for possible inclusion in indoor residual sprays (IRS) or mosquito 
nets to identify compounds with intrinsic activity against mos-
quito vectors (World Health Organisation, 2006). Topical applica-
tion is suitable as a rapid first stage in a screening cascade, where 
screening large numbers of compounds through tarsal contact 
may not be logistically feasible. Much smaller quantities of 
compound are required for topical application, which is an 
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Table 2. Effect of tarsal contact with 20 compounds, with/without RME, on adult female 
Anopheles gambiae. There were 20 compounds applied in acetone to a glass plate and allowed to 
dry before mosquitoes were exposed to the surface and scored for knock down and mortality  
60 minutes and 24 hours, respectively, after exposure. Percentages have been corrected for 
negative control mortality using Abbott’s formula (Abbott, 1925). Compounds indicated as being 
unclassified have not been listed by IRAC (2018). ND indicates a data point which was not collected.
Compound 
(IRAC Class)
Conc. 
(mg/m2)
Compound alone Compound + RME Breakpoint 
with RME 
(mg AI/m2)Mean % Knock Down
Mean% 
Mortality
Mean % 
Knock Down
Mean % 
Mortality
Dinotefuran 
(4A)
125 100.00 100.00 100.00 100.00
1.25
25 79.17 100.00 93.75 100.00
5 31.03 86.21 97.14 100.00
1.25 28.00 64.00 93.33 100.00
0.25 6.06 15.15 14.29 78.57
0.05 10.00 0.00 3.85 42.31
Clothianidin 
(4A) 
125 11.99 35.71 68.00 100.00
0.25
25 12.95 31.25 89.45 100.00
5 59.03 67.65 96.38 100.00
1.25 60.71 60.00 82.94 100.00
0.25 3.94 6.90 40.00 96.55
0.05 9.60 9.38 0.00 78.13
Sulfoxaflor 
(4C) 
125 6.36 70.91 82.14 96.43
5
25 0.00 40.94 96.55 100.00
5 0.00 26.36 35.71 85.71
1.25 0.00 6.67 0.00 58.62
0.25 0.00 3.03 6.90 10.34
0.05 5.90 0.00 0.00 11.11
Triflumezopyrim 
(4E) 
125 ND ND ND ND
5
25 36.67 50.00 60.71 96.97
5 6.36 20.00 9.09 81.82
1.25 10.37 35.56 0.00 62.22
0.25 0.00 0.00 8.82 25.07
0.05 0.00 0.00 6.67 6.73
Spinetoram 
(5) 
125 7.69 73.08 0.00 100.00
25
25 9.68 29.03 22.50 100.00
5 3.33 10.00 0.00 71.82
1.25 7.69 7.69 6.58 45.10
0.25 7.41 3.70 7.14 40.00
0.05 0.00 6.45 0.00 0.36
Ivermectin 
(6)
125 5.00 100.00 0.00 100.00
0.25
25 5.00 100.00 0.00 100.00
5 0.00 100.00 10.00 100.00
1.25 0.00 70.00 0.00 95.00
0.25 0.00 10.00 0.00 95.00
0.05 0.00 5.00 5.00 60.00
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Compound 
(IRAC Class)
Conc. 
(mg/m2)
Compound alone Compound + RME Breakpoint 
with RME 
(mg AI/m2)Mean % Knock Down
Mean% 
Mortality
Mean % 
Knock Down
Mean % 
Mortality
Avermectin 
(6) 
125 20.94 100.00 ND ND
0.25
25 2.00 100.00 37.50 100.00
5 9.00 37.00 21.21 100.00
1.25 3.45 3.45 14.71 97.06
0.25 0.00 0.00 39.29 92.86
0.05 0.00 0.00 0.00 24.14
Abamectin 
(6) 
125 17.86 96.43 0.00 100.00
1.25
25 13.33 100.00 46.88 100.00
5 6.90 89.66 35.48 100.00
1.25 10.34 41.38 55.88 94.12
0.25 3.33 20.00 9.09 66.67
0.05 0.00 0.00 13.79 13.79
Diafenthiuron 
(12A) 
125 0.00 3.23 ND ND
>25
25 6.90 10.34 0.00 48.17
5 0.00 6.45 0.00 0.00
1.25 10.00 10.00 1.59 1.02
0.25 3.45 0.00 0.00 0.00
0.05 0.00 0.00 0.00 0.00
Fenpyroximate 
(21A) 
125 22.73 59.09 100.0 100.0
5
25 12.90 16.13 100.00 96.28
5 9.68 6.45 85.03 82.01
1.25 7.14 21.43 45.63 61.66
0.25 8.00 4.00 13.94 10.05
0.05 15.38 3.85 2.71 31.64
Tolfenpyrad 
(21A) 
125 70.37 100.00 86.21 100.00
5
25 12.50 3.13 91.18 97.06
5 7.41 11.11 82.86 88.57
1.25 7.14 7.14 53.33 46.67
0.25 0.00 3.33 43.75 18.75
0.05 3.23 0.00 24.14 17.24
Pyridaben 
(21A) 
125 42.72 14.49 75.06 90.00
25
25 43.31 7.05 96.44 100.00
5 23.78 0.00 69.94 68.75
1.25 32.37 0.00 38.45 36.36
0.25 17.86 0.00 0.00 3.23
0.05 34.17 38.83 9.81 15.63
Fenazaquin 
(21A) 
125 20.88 21.55 80.00 80.00
125
25 20.83 0.00 63.64 33.33
5 8.33 3.33 17.65 5.88
1.25 9.44 6.11 3.23 3.23
0.25 0.00 6.67 3.57 7.14
0.05 3.03 0.00 3.23 0.00
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Compound 
(IRAC Class)
Conc. 
(mg/m2)
Compound alone Compound + RME Breakpoint 
with RME 
(mg AI/m2)Mean % Knock Down
Mean% 
Mortality
Mean % 
Knock Down
Mean % 
Mortality
Pyrimidifen 
(21A) 
125 54.07 46.67 90.63 81.25
25
25 50.00 6.67 100.00 100.00
5 6.67 6.67 51.61 54.84
1.25 0.00 0.00 17.86 3.57
0.25 0.00 0.00 10.00 10.00
0.05 0.00 0.00 17.86 14.29
Indoxacarb 
(22A) 
125 3.03 1.55 3.33 100.00
25
25 3.33 10.00 3.23 93.55
5 0.00 0.00 0.00 76.92
1.25 2.78 2.80 3.45 31.03
0.25 0.00 0.00 6.45 6.45
0.05 0.00 0.00 0.00 0.00
Metaflumizone 
(22B) 
125 3.33 3.33 7.41 64.55
5
25 0.00 3.33 3.33 100.00
5 0.00 0.00 6.67 100.00
1.25 0.00 3.33 0.00 61.11
0.25 0.00 3.33 3.33 16.67
0.05 0.00 6.67 3.33 3.33
Tyclopyrazoflor 
(Unclassified) 
125 33.33 73.33 64.29 64.29
>125
25 23.70 68.89 28.13 59.38
5 10.00 40.00 22.58 35.48
1.25 3.03 3.03 17.24 13.79
0.25 6.67 7.04 0.00 0.00
0.05 0.00 0.00 0.00 6.45
Oxazosulfyl 
(Unclassified) 
125 3.33 3.33 36.67 100.00
5
25 3.33 6.36 43.33 100.00
5 0.00 13.89 50.00 90.00
1.25 0.00 0.00 56.67 60.00
0.25 3.33 0.00 3.33 3.33
0.05 0.00 0.00 0.00 6.90
Benzpyrimoxan 
(Unclassified) 
125 3.33 6.67 3.13 0.00
>125
25 0.00 3.33 0.00 7.14
5 0.00 0.00 0.00 0.00
1.25 0.00 0.00 0.00 7.14
0.25 0.00 3.33 0.00 0.00
0.05 0.00 6.67 0.00 3.57
Dicloromezotiaz 
(Unclassified) 
125 0.00 3.33 0.00 13.33
>125
25 0.00 0.00 0.00 3.33
5 0.00 0.00 6.67 6.67
1.25 0.00 0.00 0.00 6.06
0.25 0.00 0.00 19.35 25.81
0.05 0.00 0.00 24.14 24.14
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Figure 3. The 24-hour mortality dose response curves and discriminating doses of the 11 shortlisted compounds. Dose response 
curves were produced by measuring mortality of adult female Anopheles gambiae mosquitoes exposed to dried deposits of compounds 
applied in acetone to the inside of a bottle, in a version of the CDC bottle bioassay. Discriminating dose is calculated as the LC95 multiplied 
by 3.
important consideration when compounds can be costly to 
purchase or to synthesise.
The WHO guidelines recommend tarsal exposure of mosquitoes 
to compound applied to filter paper in a WHO tube assay as the 
next step in screening potential new insecticides (World Health 
Organisation, 2006). However, to minimise the quantities of 
compound required, a method that involved exposing mosqui-
toes to small treated Petri dishes was developed to determine 
efficacy through tarsal contact, the typical route of exposure of 
mosquitoes to the chemistries used in IRS and LNs. 
Of the five compounds which failed to reach the activity 
threshold in the topical application screening, but which were 
taken forward to tarsal testing to validate the screening cascade 
as a whole, all showed little or no activity in the tarsal contact 
assay. Of the 14 compounds which reached the 80% threshold 
for activity in topical application, all were also active in the tarsal 
contact assays in the presence of an adjuvant, although not always 
without adjuvant. A good correlation was seen between the results 
of the two testing stages, with activity of active ingredients when 
applied topically being a good predictor of tarsal contact activity, 
with compounds having very low intrinsic activity being screened 
out in the process. The final stage in this testing cascade, the 
calculation of DD based on 24-hour mortality in mosquitoes 
exposed to a treated bottle, was included to provide robust data on 
the relative potency of the shortlisted compounds. Combined with 
information on cost of goods information, this provide information 
on the cost-efficacy of a compound. The WHO recommends the 
use of twice the calculated LC99.9 values determined by baseline 
susceptibility testing against a susceptible laboratory strain or a 
susceptible field population of mosquitoes as the DD (World 
Health Organisation, 2018). However, using the LC99.9 is prone 
to error since the confidence intervals are typically wider at the 
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Figure 4. Relative Potency of Compounds assessed by discriminating dose and tarsal contact assay with RME. Compounds in the 
shortlist ranked from highest (1) to lowest (11) potency according to the breakpoint concentration in the tarsal contact assay with RME is 
plotted against the rank assigned according to the DD. Where compounds have the same breakpoint they were assigned the same rank and 
ranks skipped correspondingly.
extreme lower and upper range of LC values, and a much greater 
number of replicates are required to achieve an accurate estimate 
(Robertson et al., 1980). For this reason, a DD of three times the 
calculated LC95 was used in this screen.
The inclusion of a concentration range in the tarsal contact assay 
was designed to give more quantitative data and allow compounds 
to be selected for progression based on level of activity, with a 
breakpoint concentration for each being used as a measure of 
potency. However, there was a poor correlation between this 
breakpoint and the DD for the final list of proposed compounds, 
and activity in the tarsal contact assay was a poor predictor of 
DD. Clothianidin had the lowest DD (i.e. was the most potent) 
of the compounds on the shortlist and reached 80% mortality 
24 hours after exposure to the lowest dose used in the tarsal contact 
assay with RME, which none of the other shortlisted compounds 
achieved. However, this does not hold true with the other 
compounds. For example, spinetoram was the second most potent 
of the compounds in terms of DD but was relatively inactive in 
the tarsal contact assay with RME. There are some key differ-
ences in the format of these assays which may go some way to 
explaining this discrepancy. For example, for a compound hav-
ing a higher volatility, the greater quantity of compound applied 
to the inside of the sealed bottles used in the bottle bioassay may 
have a disproportionate effect relative to the smaller surface area 
and more ventilated environment of the tarsal contact assay. The 
small number of mosquitoes used in each tarsal contact assay 
may also lead to a certain level of ‘noise’ in the data not seen with 
the larger scale of the dose response assays which along with the 
more robust analysis, means that the ranking of compounds for 
potency is likely to be more accurate based on the DD analysis 
than on the earlier stages in the testing cascade.
When viewed together, the data collected on the compounds 
evaluated through this screening cascade suggest that a topical 
application screen is sufficient to eliminate compounds without 
sufficient intrinsic activity against the target mosquito species, 
and that calculating the DD is the most informative subsequent 
assay for the selection of the most potent compounds for further 
development. This more streamlined screening cascade, without 
the inclusion of the tarsal contact assay, may be an efficient way 
to identify compounds with potential for development for LN or 
IRS products. Other tests may be required to identify compounds 
suitable for use in other product classes. Flupyradifurone, for 
example, was rejected based on low efficacy in the topical 
screen but has since been developed into a space spray product 
by Bayer Vector Control, Fludora® Co-Max EW, in combination 
with Transfluthrin. It may be that atomisation of the compound 
into small droplets that contact across a greater area of the mos-
quito serves to increase potency, and that inclusion of a screen-
ing methodology such as a wind tunnel may be valuable for those 
compounds which are not shown to be active in topical applica-
tion. Volatile insecticides with potential for use in commercial 
household insecticide emanators might be better tested in an 
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Figure 5. Chemical structures of the shortlisted compounds. From the 40 compounds taken through the testing cascade for repurposed 
pesticides, 11 are highlighted as potentially suitable for use against mosquito vectors of malaria in an insecticide treated net. Their chemical 
structures are presented here. Compounds are arranged by IRAC MoA class, class 4 Nicotinic acetylcholine receptor competitive modulators 
on the first row, class 22 Voltage-dependent sodium channel blockers on the second, and mitochondrial complex 1 electron transport 
inhibitors on the third. Abamectin is Class 6, a glutamate-gated chloride channel (GluCl) allosteric modulator, spinetoram is Class 5, a 
nicotinic acetylcholine receptor (nAChR) allosteric modulator – Site I. Oxazosulfyl is not listed by IRAC.
assay which exposes mosquitoes without physical contact with a 
compound.
The importance of including an adjuvant
Where tarsal contact assays are to be used to screen com-
pounds for activity against mosquitoes, this study demonstrates 
how important it is for an adjuvant to be applied to the treated 
surface along with the active ingredient. Of the 11 compounds 
shortlisted by following this testing cascade, eight would have 
been rejected as having insufficient tarsal efficacy when applied 
to bottles with acetone alone but, with the addition of the adjuvant 
RME, reached the acceptable threshold of activity: sulfoxaflor, 
triflumezopyrim, spinetoram, fenpyroximate, oxazosulfyl, clo-
thianidin and indoxacarb. Each of these compounds, with the 
exception of oxazosulfyl, which was not included in their screen, 
were rejected by Hoppé et al (2016) as having too low an activity 
against Aedes aegypti, and in some cases also against Anopheles 
stephensi. Although differential activity of insecticides against 
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different species is sometimes seen, the inclusion of an adjuvant 
is a potential explanation, or at least partial explanation, for this 
lack of correlation between studies. Of particular note on this 
list is clothianidin, which is the active ingredient in Sumishield 
50WG and Fludora Fusion, IRS products produced by Sumitomo 
Chemicals and Bayer Crop Science, respectively, which was 
found to be inactive against Aedes aegypti though not tested 
against An. stephensi (Hoppé et al., 2016). 
Susceptibility testing of clothianidin is performed by Sumitomo 
Chemical using the CDC bottle bioassay (Brogdon & Chan, 2010) 
with the addition of 500 µg/bottle Span 80, a surfactant. The 
addition of Span 80 is shown to prevent the formation of large 
crystals of clothianidin on the glass surface which form particu-
larly at high concentrations and are correlated with the reduction 
of mortality in exposed An. gambiae (Ohashi et al., 2018). Using 
this method and a 2-hour exposure time a DD of 20 µg/bottle was 
determined for clothianidin in the presence of Span 80 and a much 
lower potency was measured in its absence. Since the current 
study calculated the DD to be less than half this with a 60-minute 
exposure it is possible that RME may be a more effective 
adjuvant than Span 80, although variations between experimen-
tal conditions cannot be discounted as an alternative explana-
tion. In its current multi-centre study to identify discriminating 
doses, the WHO is including RME in the methodology for 
clothianidin, as well as for flupyradifurone and imidacloprid 
(Corbel, personal communication). 
The activity of a suspension concentrate formulation of 
indoxacarb has been demonstrated on treated nets against 
Anopheles gambiae and Culex quinquefasciatus (Oxborough 
et al., 2015a), which again would have been rejected follow-
ing testing without the addition of RME but was included in the 
final shortlist of proposed compounds in this study. The neonico-
tinoid dinotefuran has been shown to be toxic against strains of 
Anopheles gambiae Giles, Culex quinquefasciatus Say, and Aedes 
aegypti L carrying commonly found resistance mechanisms, and 
may be even more effective against mosquitoes resistant due 
to insensitive acetylcholinesterase (Corbel et al., 2004) and is 
proposed for use in attractive toxic sugar baits (ATSBs) against 
mosquitoes (Khallaayoune et al., 2013). This active ingredient 
was shown not to be active against Aedes aegypti in the absence 
of an adjuvant by Hoppé et al. (2016), whereas the activity 
was shown in the present study to be enhanced by the addition 
of RME and it was included in the final short list. 
Speed of kill
Pyrethroids and other classes of insecticide that have, until 
recently, been used in vector control are fast acting, and it is upon 
the particular modes of action of these compounds that the cur-
rent WHO guidelines for screening compounds for efficacy and 
cross-resistance are based (World Health Organisation, 2006). 
However, there is a growing number of chemistries being 
repurposed from agricultural and other uses into mosquito vec-
tor control, which do not rapidly knock down mosquitoes or 
kill within 24 hours, but which can still be effective in control-
ling malaria vector mosquitoes when used in IRS or LN prod-
ucts. Notably, reports of trials of clothianidin as an IRS indicate 
much longer residual efficacy if mortality of exposed mosquitoes 
is assessed for several days after exposure than if the standard 
24-hour endpoint is used (Agossa et al., 2018; Uragayala et al., 
2018). For these compounds, assessing the mortality over a longer 
period post-exposure and even assessing sub-lethal effects may 
need to be taken into consideration (Oxborough et al., 2015b). 
Sulfoxaflor, spinetoram, fenpyroximate and pyrimidifen were 
judged to be fast acting and ivermectin, abamectin and metaflu-
mizone particularly slow acting based on topical application. No 
compound exhibited substantial knock down activity in tarsal 
contact assays in the absence of RME but, with the addition of 
RME, the majority of mosquitoes exposed to dinotefuran, fenpy-
roximate, pyridaben, fenazaquin and tolfenpyrad were affected 
immediately post-exposure at the breakpoint concentration. The 
differences in observation between these two bioassays may be 
due to a difference in the means of exposure. Speed of action is 
a function of both the mode of action and the physical properties 
of a compound so that even compounds that act on the nervous 
system of insects may be slow acting if it takes the compound 
some time to traverse the cuticle barrier and reach the target 
site. RME seems to help speed up the movement of some active 
ingredients across the cuticle, thus speeding up their action and 
making them effective at lower doses. Several compounds were 
highly effective based on mortality at 24 hours, but had extremely 
low knock down rates, which must be taken into consideration 
when developing new treated net products as exposure to them on 
a LN may not result in any significant blood feeding inhibition. 
Therefore, when considering possible mixture partners of 
compounds for use in LNs, it will be important to consider 
speed of action and to pair compounds where at least one of 
them is fast acting. 
In the tarsal contact assay, no great difference was detected between 
mortality at 24 hours and 48 hours, and in the topical applica-
tion screen the increase in mortality was not great over this same 
period for any compound tested. It is possible, however, that longer 
periods of mortality assessment might have shown a greater 
efficacy for some of the slower-acting, non-neurotoxic compounds, 
as has been reported for clothianidin (Agossa et al., 2018; 
Uragayala et al., 2018). The high level of knock down and 
24-hour mortality seen with clothianidin seems to be at variance 
with these studies, although the high potency of the compound 
may mean that the concentrations used in the tarsal contact assay, 
standard for all compounds in the screen, were high enough 
to cause a rapid effect which might not be seen at operational 
doses. The speed of action judged from topical and from tarsal 
exposure routes were not in complete agreement, an observation 
which warrants further investigation.
Additional compounds considered for their potential value
During the course of this study, six additional compounds were 
considered for inclusion, but not taken through the complete 
testing cascade (Supplementary Data, included in Raw Data 
file). Diflumetorim, a mitochondrial complex 1 inhibitor, and 
acynonapyr, an acaricide with unclassified mode of action, were 
screened for tarsal activity with RME, but did not reach 80% mor-
tality at the highest concentration tested (125 mg/m2) (Lees et al., 
2019). Pyflubumide, IRAC class 25A, a Beta-Ketonitrile deriva-
tive, pyriministrobin, IRAC class 20, and flometoquin, unclas-
sified by IRAC, were screened for tarsal activity both with and 
without RME but did not reach 80% mortality at the highest con-
centration tested (125 mg/m2) in either assay (Lees et al., 2019). 
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Fluralaner (IRAC Class 30), a GABA-gated chloride channel 
allosteric modulator and, therefore, representing a novel mode 
of action for public health, is currently under consideration for 
use as an endectocide (Miglianico et al., 2018). In this screening 
study it was effective in tarsal contact assays at the higher con-
centrations, particularly when mortality was scored at 48 hours, 
both with and without the presence of an adjuvant (Lees 
et al., 2019). Very little knock down was observed at any 
concentration.
The shortlisted compounds: 11 repurposed chemistries 
with potential for use in public health
A total of 11 compounds from eight IRAC classes and 
oxazosulfyl (which is unclassified by IRAC) were shortlisted at 
the conclusion of this testing cascade on the basis of their bio-
logical efficacy against a pyrethroid susceptible lab colony of 
Anopheles gambiae. Two of these, both from the neonicotinoid 
IRAC class 4, have now been formulated into products for 
malaria control: clothianidin is the active ingredient in two IRS 
products, SumiShield™ 50WG (from Sumitomo Chemical) and 
Fludora®Fusion (from Bayer Crop Science, in combination with 
deltamethrin); and dinotefuran is being evaluated in trials of 
attractive targeted sugar baits (Khallaayoune et al., 2013). Oxa-
zosulfyl is in development against rice pests by Sumitomo under 
the trade name Alles™. Indoxacarb (IRAC class 22 Voltage- 
dependent sodium channel blocker) was developed by DuPont 
as an oxadiazine pesticide against lepidopterans and has been 
formulated into a line of commercial pesticidal products by 
Syngenta: Advion and Arilon. Spinetoram (IRAC class 5) is 
a derivative of biologically active substances (spinosyns) pro-
duced by the soil actinomycete Saccharopolyspora spinosa, 
discovered Dow AgroSciences LLC. and sold as Radiant® SC. 
Spinetoram affects nicotinic acetylecholine receptors and GABA 
receptors on postsynaptic membranes in insect nervous systems, 
thereby causing abnormal neural transmission. Metaflumizone 
is a novel semicarbazone insecticide (IRAC class 22B) derived 
chemically from the pyrazoline sodium channel blocker insec-
ticides (SCBIs) discovered at Philips-Duphar in the early 1970s. 
This compound is a novel sodium channel blocker insecticide, 
which blocks sodium channels by binding selectively to the slow- 
inactive state which is characteristic of SCBIs (Salgado & 
Hayashi, 2007). Abamectin is a macrocyclic lactone that acts 
through chloride channel activation. Discovered in 1981, this com-
pound has been shown to be active in contact bioassays against 
house flies, cockroaches and fire ants, and has been employed 
in combination with fenpyroximate as a novel durable wall 
lining (Malima et al., 2017). Sulfoxaflor is from the sulfoximine 
class of compounds (IRAC class 4C) which are structurally 
distinct from neonicotinoids. This compound is marketed 
by Dow AgroSciences as Isoclast™ Active for use against sap- 
feeding insect pests. Triflumezopyrim, belongs to the novel 
class of mesoionic insecticides (IRAC class 4E), binding to the 
orthosteric site of the nicotinic acetylcholine receptor and, 
therefore, also distinct from the neoniconoids (Cordova et al., 
2016). Triflumezopyrim is being commercialized by Corteva 
Agriscience for control of hoppers, including the brown plan-
thopper, Nilaparvata lugens, including populations showing 
resistance to neonicotinoids such as imidacloprid (Zhang, 2017). 
Tolfenpyrad and fenpyroximate are classified by IRAC in Group 
21A mitochondrial electron transport inhibitors which inhibit the 
electron transfer system of energy metabolism and respiration 
in the mitochondria of susceptible insects. Tolfenpyrad has been 
employed within an ATSB system in studies in Tanzania (Stewart 
et al., 2013), and fenpyroximate is a broad spectrum acaricide 
which has been employed with abamectin as a novel durable 
wall lining (Malima et al., 2017).
There are non-entomological parameters to be considered 
before deciding which of the shortlisted compounds should be 
progressed for consideration as a component in a vector control 
product, including physiochemical properties and suitability 
for use on an LN, human safety risk assessment and cost of 
production. Crucially, the efficacy of these compounds must 
also be assessed against mosquitoes resistant to pyrethroids 
and other existing classes of insecticide to check for any pre- 
existing cross-resistance. Although the modes of action of these 
shortlisted compounds are novel to mosquito control, cross resist-
ance in field strains may occur through metabolic detoxifica-
tion which is not related to mode of action (David et al., 2013) 
and is the predominant form of resistance in populations of 
Anopheles funestus, where the kdr point mutation is absent 
(Tchigossou et al., 2018). Cross resistance, should it be identified, 
would likely make a compound unsuitable for progression.
Conclusion
A screening cascade for evaluating the potential of existing 
insecticidal compounds for repurposing into control tools against 
malaria vectors has been developed. This was used to screen 
40 compounds for intrinsic activity and tarsal contact activity, 
and to determine relative potency. The inclusion of the adjuvant 
RME was shown to be critical to avoid eliminating compounds 
where efficacy could be improved through formulation. A more 
streamlined testing cascade is suggested, that relies on topi-
cal application and determination of discriminating dose in 
the presence of an adjuvant. This would allow for screening of 
compounds to progress more quickly, but without losing criti-
cal information, although further validation of this streamlined 
testing cascade is required. There were 11 compounds were 
identified offering novel modes of action in public health, a 
critical step in the development of products that can control 
insecticide resistant populations of Anopheline vectors of 
malaria. The next key step in progressing these compounds towards 
product development will be to assess their efficacy against 
strains of Anopheles expressing resistance to existing vector 
control insecticides, to assess cross resistance risk. Additional 
information, beyond entomological efficacy, must also be con-
sidered when assessing the suitability of these compounds for 
development into new vector control tools, including safety, 
cost efficacy, and physicochemical properties relating to product 
formulation.
Data availability
Figshare: A comprehensive testing cascade to identify resistance 
breaking repurposed insecticides for next generation vector 
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control tools: screening a panel of chemistries against a malaria 
vector - Raw Data. https://doi.org/10.6084/m9.figshare.c.4490246. 
v1 (Lees et al., 2019).
This collection contains the following underlying data:
•    Raw data Phase 1 Topical Application.xlsx (raw data for 
topical application of 40 compounds for 60-min knock down 
and 24- and 48-hour mortality).
•    Raw data Phase 2 Tarsal Contact Assay.xlsx (60-min knock 
down, and 24- and 48-hour mortality observations of mosqui-
toes exposed to insecticides applied to a glass petri dish).
•    Raw data Phase 3 Discriminating Doses.xlsx (24-hour 
mortality data from CDC bottle bioassay dose response 
experiments used to calculate LC values for 11 compounds).
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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